Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
yeah I have just been waiting for enough people to realize what I THINK is going on,seems there is a big group forming from what I understand who want the truth about this company......we will organize and hire a private firm to do all the discovery as we did with PRONETLINK.COM we started with the sec but those people are watching porn and spending their time in the bathroom it seems..... they dismissed our evidence early on ,then we hired a firm to dig deep we proved our case easily and received satisfaction as we broke and jailed the owner and got most of our money back.... I find satisfaction in the fact that we as a group each spent a few hundred bucks on discovery and all investors received the same percent return,I am still wishing for a bigger group I WILL TRY TO GET AN INVESTED LIST THROUGH THE SEC AND PERHAPS WORK OFF THAT
is this our ray,lol getting juicy now
One of those scofflaws is Raymond Dabney, former president and chief executive officer of Xraymedia Inc., a Vancouver-based company that traded on the OTC Bulletin Board in the United States.
In August 2005, Dabney, who has a penchant for gold jewelry and big talk, admitted to issuing 22 false news releases. He agreed to a five-year stock market suspension and a $30,000 fine, but so far he hasn’t paid a cent.
Now he’s in more trouble.
This week, the U.S. Securities and Exchange Commission named him, his brother Richard, and four others in a complaint filed in U.S. District Court in Arizona.
The complaint alleges that Richard Dabney, who lived in Torrance, Calif., and two others manipulated the market for a bulletin board company called Alliance Transcription Services Inc. by issuing false news releases in 2005 and 2006, and Raymond Dabney assisted in the illegal issuance of unregistered Alliance shares.
The SEC has asked the court to impose civil penalties and permanently bar the brothers from the U.S. securities market.
does not matter next week all will be invited to join in the soon to be announced ..............all the questions will be answered soon,believe me.............. been there done that............
what are ya looking for Dade
lol imo
lets see this stock used to trade at 1.40......now a nickel they continually dump shares or someone continually dumps shares probably out of the canadian exchanges we have yet to see the fruition of any news release from day one now some dividend scam to most likely wipe out commons in the end give shareholders .00001 on the dollar and still exactly where they were as a company on day one at 1.40....lol
finally the new warehouse/media center/lab/growing room/corporate offices http://www.pbase.com/tkgross/image/113809714
actually the last two news releases were a hint at what the future could be ,now the company just has to prove that it is not all bulshitt,we need a few dollars revenue,a pic of the new lab,and a hint as to what we shareholders gave 25 million shares for,oh and what was that patent pr about
lol,the trend is down,there is no "news" no revenues no end to the dumping of shares,smoke a bowl and get some balls,sell this crap,these folks are fnn burnt out ,they keep releasing the same crap prs looking for another opp to dump more shares or so it seems...
i would rather one of the patented drugs cbis is supposed to have gets the nod across the pond asap http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/7973707/Canada-approves-GW-Pharmas-cannabis-based-drug.html
over 100k here nothing compared to pumper @ 2 mil,sure miss sparing with him he ,for a name calling bully a pretty fun guy...........not
wp....hope this is all true,thanks
oh yeah! this is awesome, all makes perfect sense now! http://www.blogtalkradio.com/virmmac/2010/08/30/cannabis-science-inccbis-ceo-dr-robert-melamede-live-on-stocktalk101-radio
I am happy for you,today we met with hospice folks from the local hospital is the only reason I am not at my job, and it may appear that I am my own worse enemy picking on a stock I own. I can only be honest with myself and others as well, to do otherwise imo is fraud.....and yes this co.pisses me off greatly.waiting 2 weeks for a return phone call...........yet some post here that mark is telling them great things to be announced shortly,yeah right
well as the stock price climbs on real news... the homes you want keep plummeting in price is your best case scenario......do you really believe we will ever hear another word about todays news release,from past experience I do not, but I would love to be wrong
you made 600k on cbis?
hi Lars,I truly hope you are right I want us ALL to prosper,as I have said before I do believe our cbis leaders should profit hugely on this product as reward for all their years leading the charge in the trenches.While I have been an advocate for many years, I don`t use mj but that could change any day now.lol
inside info,cool I believe ya
when a company quits lying to shareholders is always a good start when they don`t have a disclaimer that says anything we say is never to be updated or commented on again,lol
oh man the whole thing is sharklike,lol it was from a jan.news release, all hyped up crapploa that is now part of their pr graveyard,hence the cry wolf analogy
Cannabis Science Outlines Objectives For The New Year; Highlights Include Moving Towards Contracts & Licensing Agreements For...
Gulf (OTCBB:CBIS)
Historical Stock Chart
Cannabis Science Inc. (NASD OTCBB: CBIS), an emerging pharmaceutical cannabis company, is pleased to announce Cannabis Science is in negotiations with several companies in the US and internationally to contract or license its formulations for development, certain rights to manufacturing processes, and the sale in each prospective jurisdiction and or country.
Cannabis Science President & CEO, Dr. Robert Melamede, stated, "We are able to greatly accelerate our company's progress in the New Year by working with others doing research and sales for our cannabinoid medicines by entering into licensing agreements with them. We expect to have definitive agreements signed in the near future."
yeah good idea, post the # here so curious investors and perhaps big money fund guys can call as well
another pr without teeth,we could break down to .045 the little boy who cried wolf scenario
Oh yeah, buy another 2 million shares I am only trying to get the price lower,I mean what the heck over 10 people read this board and our lively discussion has a huge affect on pps, yes it is true..... huge,giant big and glorious news to be released very soon,buy buy buy.do your own dd I would start with the people who set this co. up and move on to the stock promoters,read and verify all prs,you can call the company, their phone number is listed and a bright cheerful person will answer all your questions and if they cannot they will get you in touch with a person who can,very quickly I might add...............
THIS CAUSED A PRETTY BIG POP IN THE PPS THEN A HUGE DUMP WHERE IS THE NEAR VERY SOON RELEASE OF NEWS http://ih.advfn.com/p.php?pid=nmona&article=41058239&symbol=OTCBB%3ACBIS
oh darn, now I know why they just throw news out and never update or let us shareholders know they are fulfilling their responsibilities under the law,they have a disclaimer,it says we can news you all we want and we don`t have to back it up,ever????? lol....................................................... Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
CONTACT: Cannabis Science Inc.
OK...I AM FULL OF IT!!!!! BUT SO ARE SOME HERE WHO PUMP THIS THING, WHERE IS THE MONEY.....WHAT DID THEY SPEND IT ON? THAT IS A GOOD QUESTION,,,,,WHY DID THEIR OWN BOARD MEMBER AND AN ALLIANCE THROW THEM UNDER THE BUS....SOMEBODY IS IN TROUBLE HERE AND I THINK IT IS US AND TO A BROADER DEGREE THE GUYS RUNNING THIS TRAINWRECK,IT WILL ALL COME OUT IN THE END,WHO SOLD WHAT AND WHEN WHAT WAS TRUE AND NOT TRUE....HAVE THE PEOPLE RUNNING THIS COMPANY SHOWN ONE OUNCE OF INTEREST IN SHAREHOLDER VALUE,,,,SEEMS NOT.... THEY BETTER DO SOMETHING ,THERE ARE 14 STATES WHERE PEOPLE ARE BECOMING VERY RICH THROUGH MJ SALES AND WE CAN`T MAKE A 100 D0LLARS IN A YEAR,WHAT IS UP WITH THAT,WAS THE PLAN JUST TO RUN THE COMPANY OFF STOCK DUMPS AND PRS WITHOUT FOLLOW UP..... ASK YOURSELF THOSE QUESTIONS AND QUIT ATTACKING ME.... I CAN PROVE MY OWNERSHIP OF SHARES,THE COMPANY I INVESTED IN DOES NOT EVEN ANSWER THE PHONE OR RETURN PHONE CALLS IS MY EXPERIENCE SO FAR
this tells me they are in the same position they were on day one......they have an idea about something but no action has taken place yet ,no product,no patents, little research,if any............. Cannabis Science President and CEO Dr. Robert Melamede, PhD., whose mother was German, remarked, "Germany's recognition of the medical value of cannabis coincides with our plans for expansion into Europe. We hope that America is not going to squander its lead in medical cannabis research, but Cannabis Science will certainly work with German and other European researchers and clinicians to develop medical cannabis products that meet the needs of patients around the world." would have been better to hear that we have the solution to the problem and Germany will accapt it as medicine but....no just more blather about some future working relationship with some unknown entities,lol get a grip people
when did you make that trade.......do you think my 100,000 shares will get me to see mickey mouse
some fool dumped 250,000 shares today,poor dumb person I guess... if the mms were wanting to hold their shares... would they not do a little modification on the bid and ask,seems they are propping up the price to unload their shares to me,but please tell me if I am wrong and splain it to me so I can follow.. type slow I can`t read fast tia
rah rah,i think it is the quality of the news releases,but hey we get to entice some foreign investors,perhaps in the near future,ya never know now do ya,anybody find that new leased space yet,that was the pr that sold me on these guys,,,,,they were able to sign a long term lease......that is big,and Dr.Bobs mom is German.......
COLORADO SPRINGS, Colo., - Cannabis Science, Inc. (OTCBB:CBIS - News), a pioneering U.S. biotech company developing pharmaceutical cannabis products, is pleased to announce that it has acquired 100% of a private company with two revenue producing operations, an organic medical marijuana growing facility and a medical marijuana dispensary providing patients with medical marijuana in Colorado in accordance with state laws.
Richard Cowan, Cannabis Science CFO, stated, "Obviously, acquiring two revenue producing operations immediately changes the nature of Cannabis Science, giving us a positive cash flow stream much sooner than otherwise would have been possible. We are now entering a new phase of our business and we expect to expand these revenue streams immediately by the acquisition of a larger facility as previously announced to meet the demand for Cannabis Science products. Our main focus remains the development of pharmaceutical cannabis products for FDA approval. In fact, these acquisitions will improve our ability to develop pharmaceuticals and increase our ability to serve the rapidly growing patient community."
Currently, both operations are producing revenues in the hundreds of thousands of dollars and generate significant positive cash flow. The transaction was a share swap in which the company is issuing a total of 2,400,000 shares for both the acquisition of these operations and as compensation for a management contract that will add significant skills to our company's team. The seller of these facilities, Mr. Adam Pasquale, is joining the Cannabis Science management team as Director of Horticulture. Mr. Pasquale's responsibilities include overseeing these operations and implementing the company's plans to expand these areas of business across the country, as the laws allow. The Company is looking forward to regularly reporting its progress in its 5 key operations:
1. The Horticulture Division -- Pharmaceutical Grade Medical Cannabis Grown Under Stringent Quality Controls.
2. Analytical Labs -- State Of The Art Facilities Developing Cannabis Extracts and Pharmaceutical Grade Drugs.
3. Manufacturing -- Cutting Edge Facilities For Creating Oral and Topical Medications For Various Ailments.
4. Clinical Trials -- Initial FDA Clinical Trials Targeting Veterans Suffering From Chronic Pain and PTSD.
5. Distribution -- In State Dispensaries Today, National Pharmacies Tomorrow.
Dr. Robert Melamede, PhD., Cannabis Science President and CEO, said, "We view this transaction as key to our plans to develop standardized FDA quality pharmaceutical cannabis products. In addition, their profitability will facilitate our product development in accordance with State laws. These acquisitions will allow us to begin pre-testing to establish the efficacy of our pharmaceutical products prior to formal FDA human trials. We are in preliminary negotiations to establish similar operations in other States that have approved medical marijuana programs addressing the ever-increasing demands for medical marijuana as people learn the truth about marijuana's unique medical values. We are creating a new type of patient oriented pharmaceutical company that will foster social change, and this is a major step in that process."
Mr. Cowan added, "I am also very pleased to report that we are currently converting most of the company's debt into common equity. Adding revenues, eliminating debt, and clarifying the company's financial structure should help provide a higher per share price and valuation for the company. As a result of the debt conversions, the acquisition, and corporate expansions there are currently 65,570,574 shares outstanding and management expects to retire most of its debt by the end of June thereby eliminating a major source of risk. These developments should allow some of the larger funds and fund managers to invest substantially more in the company because of the reflection of our greater financial strength."
Richard Cowan continued, "Last January, the New York Times reported that a spokesperson for the U.S. National Institute on Drug Abuse (NIDA) admitted that the agency 'does not fund research focused on the potential medical benefits of marijuana.' The NIDA admission explains why these acquisitions are so important for us. It will not only facilitate our research and development; it will also serve as prototype for this sort of operation that we plan to replicate in other medical marijuana states, as well as in other countries. We think that having dispensaries with their own production facilities will allow us to produce 'Cannabis Science' branded products that will give patients the best medicine at the best prices. These transactions are further evidence of Dr. Melamede's ability to bridge the worlds of medical marijuana and hard science, and the patients -- and our shareholders -- will benefit greatly from this important step. As previously announced, our other steps toward building the company include adding a much larger analytical research laboratories, facilities for developing and manufacturing various delivery modalities such as lozenges, sprays, topical creams etc., as well as wholesale distribution of both nutraceutical and pharmaceutical products."
The National Organization for the Reform of Marijuana Laws (NORML) explained the significance of this admission:
Under federal law, the agency must approve all clinical and preclinical research involving marijuana. NIDA strictly controls which investigators are allowed access to the federal government's lone research supply of pot -- which is produced and stored at the University of Mississippi.
NIDA spokeswoman Shirley Simson told the Times: "As the National Institute on Drug Abuse, our focus is primarily on the negative consequences of marijuana use. We generally do not fund research focused on the potential beneficial medical effects of marijuana."
NIDA presently oversees an estimated 85 percent of the world's research on controlled substances.
Commenting on NIDA's admission NORML Deputy Director Paul Armentano said, "NIDA has finally admitted to the world the 'Catch-22' that has been plaguing medical marijuana advocates and patients. Lawmakers demand clinical research regarding the safety and efficacy of medical cannabis, but the agency in charge of such research denies these studies from ever taking place. It's tragic that these public officials have let political ideology, not science, determine American's health decisions."
In 2007, U.S. Drug Enforcement Administration (DEA) Administrative Law Judge Mary Ellen Bittner ruled that NIDA's monopolization of marijuana research is not "in the public interest," and ordered the federal government to allow private manufacturers to produce the drug for research purposes. In January of last year, DEA Deputy Administrator Michele Leonhart set aside Judge Bittner's ruling.
From http://norml.org/index.cfm?Group_ID=8092
About Cannabis Science, Inc.
Cannabis Science is at the forefront of pharmaceutical medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 193
YOU ARE PROBABLY AWARE THAT GERMANY IS ONE OF THE LAST COUNTRIES TO ALLOW MEDICAL MJ,WHY FLIP OUT A PRESS RELEASE ABOUT SOMETHING THEY COULD HAVE BEEN DOING FROM DAY ONE,-EUROPE- ARE THEY GOING TO RUN TO THE LAB NOW AND CREATE A PRODUCT,LOL WHO IS SELLING SO MANY SHARES EVERY DAY,DOES THAT GIVE YOU PAUSE AT ALL...........SOMEONE KNOWS SOMETHING WE DO NOT AND THEY WANT OUT BAD IT APPEARS,IS IT THEIR DREAM LEGAL STOCK PROMOTER TEAM,TIME WILL TELL.....THE HOUNDS ARE BAYING
LOL,I HATE BULLCRAP AND CBIS IMO IS A MAJOR PRODUCER....ANYWAY http://www.edmontonjournal.com/technology/Calgary+company+plans+make+bodies+from+hemp/3432196/story.html
i GUESS i INVESTED IN PAST NEWS RELEASES AND THEY ARE JUST LIKE WATER OFF A DUCKS BACK,WHAT ABOUT THE PATENT,IS THERE ANY NEWS THERE WE SHOULD KNOW ABOUT..... WHAT DRUGS HAVE BEEN DEVELOPED AND ARE READY FOR MASS MARKET.....IF THEY HAVE SUCH A GREAT NEW MOUSETRAP WHERE IS THE PRIVATE INVESTOR,WHY DID THE BOARD MEMBER STAB THEM IN THE BACK SO QUICKLY,WHAT DOES HE KNOW,WHY DID MPM THROW THEM UNDER THE BUS IN A FRICKIN HEARTBEAT,YOU TELL ME YOU HAVE 2 MILLION SHARES AND ARE PLEASED AS PUNCH...DO YOU KNOW SOMETHING THAT IS NOT OBVIOUS TO THE REST OF US WHERE IS THE MONEY GOING...........ARE THEY DOING RESEARCH,....WHAT IS GOING ON.... IS A GOOD QUESTION AS FAR AS I AM CONCERNED,NOW WE ARE JUMPING THE POND WHEN MILLIONAIRES ARE BEING MADE IN 14 STATES
Back to Google News
Colorado gov. says pot fees helping budget deficit
(AP) – 6 hours ago
DENVER — Gov. Bill Ritter is using $9 million from medical marijuana registrations to help the state meet a $60 million fiscal emergency.
The state anticipates ending the year with 150,000 applicants for medical marijuana cards, up from 41,000 in 2009. A marijuana card costs $90 per year.
Backers of medical marijuana legislation in a number of states and cities have touted revenue from possible taxes and other fees as a selling point at a time of tight fiscal funding.
Copyright © 2010 The Associated Press. All rights reserved.
it would be nice to hear that all the money that has been burned through this quarter would have some long term positive news to follow,or are they just blowing smoke........